You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 14, 2024

Stemline Therap Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for STEMLINE THERAP, and when can generic versions of STEMLINE THERAP drugs launch?

STEMLINE THERAP has one approved drug.

There are eight US patents protecting STEMLINE THERAP drugs.

There are one hundred patent family members on STEMLINE THERAP drugs in twenty-five countries and five supplementary protection certificates in five countries.

Summary for Stemline Therap
International Patents:100
US Patents:8
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Stemline Therap

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-001 Jan 27, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-002 Jan 27, 2023 RX Yes Yes 7,612,114 ⤷  Sign Up Y Y ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-002 Jan 27, 2023 RX Yes Yes 10,420,734 ⤷  Sign Up ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-001 Jan 27, 2023 RX Yes No 11,779,552 ⤷  Sign Up ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-002 Jan 27, 2023 RX Yes Yes 10,071,066 ⤷  Sign Up ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-002 Jan 27, 2023 RX Yes Yes 11,819,480 ⤷  Sign Up ⤷  Sign Up
Stemline Therap ORSERDU elacestrant dihydrochloride TABLET;ORAL 217639-001 Jan 27, 2023 RX Yes No 10,745,343 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Stemline Therap Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3122426 LUC00331 Luxembourg ⤷  Sign Up PRODUCT NAME: ELACESTRANT OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/23/1757 20230918
3122426 CA 2024 00007 Denmark ⤷  Sign Up PRODUCT NAME: ELACESTRANT OR A SALT THEREOF; REG. NO/DATE: EU/1/23/1757 20230918
3122426 PA2024504 Lithuania ⤷  Sign Up PRODUCT NAME: ELACESTRANTAS ARBA JO DRUSKA; REGISTRATION NO/DATE: EU/1/23/1757 20230915
3122426 301263 Netherlands ⤷  Sign Up PRODUCT NAME: ELACESTRANT OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/23/1757 20230918
3122426 2024C/505 Belgium ⤷  Sign Up PRODUCT NAME: ELACESTRANT OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/23/1757 20230918
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.